SLYGvsDWASETF Comparison
ETF 1
SLYG
State Street SPDR S&P 600 Small Cap Growth ETF
This fund is part of
US Small Cap Growth
+0.65%
VS
State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) belongs to the US Small Cap Growth segment. Invesco DWA SmallCap Momentum ETF (DWAS) is part of the US Multi-Factor segment. SLYG's top 3 sector exposures are Finance, Industrials and Healthcare. In contrast, DWAS's top sector exposures are Healthcare, Technology and Finance. SLYG is less expensive with a Total Expense Ratio (TER) of 0.15%, versus 0.6% for DWAS. SLYG is up 16.87% year-to-date (YTD) with +$493M in YTD flows. DWAS performs worse with 10.9% YTD performance, and -$407M in YTD flows. Run a side-by-side ETF comparison of SLYG and DWAS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
SLYG vs DWAS performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | SLYG DWAS | +1.43%-1.51% | -5.04%-3.80% | +16.87%+10.90% | +15.56%+13.32% | +63.24%+57.95% | +27.60%+18.96% |
| Flows | SLYG DWAS | -$144M-$5M | -$127M-$9M | +$493M-$407M | +$504M-$402M | +$875M-$521M | +$1.44B-$294M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | SLYG DWAS | +13.48%+23.97% | +16.85%+25.63% | +19.88%+25.32% | +21.40%+25.68% |
| Max drawdown | SLYG DWAS | -10.95%-16.21% | -10.95%-20.86% | -27.35%-33.75% | -29.18%-33.75% |
| Max drawdown duration | SLYG DWAS | 85d72d | 85d120d | 414d436d | 980d436d |
Trading data
SLYG | DWAS | |
Last sale 10/29/2026 at 1:30 PM | $111.51 | $107.43 |
| Previous close 10/28/2026 | $109.50 | $107.19 |
| Consolidated volume 10/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
SLYG | DWAS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/29/2026 at 1:30 PM
Live
Closed
SLYG | DWAS | |
|---|---|---|
| Last price | $111.51 | $107.43 |
| 1D performance | +1.84% | +0.22% |
| AuM | $4.69 B | $399.04 M |
| E/R | 0.15% | 0.6% |
Characteristics
SLYG | DWAS | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | Invesco |
| Benchmark | S&P SmallCap 600 Growth Index | Dorsey Wright SmallCap Technical Leaders Index |
| N° of holdings | 348 | 200 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 25, 2000 | July 19, 2012 |
| ESG | No | No |
Advertisement
Exposure
Countries
SLYG
USA
96.99%
Other
3.01%
DWAS
USA
99.48%
Other
0.52%
Sectors
SLYG
Finance
23.55%
Industrials
15.72%
Healthcare
15.44%
Technology
12.71%
Other
32.58%
DWAS
Healthcare
30.06%
Technology
19.85%
Finance
14.63%
Industrials
14%
Other
21.46%
Advertisement
Diversification
SLYG
Total weight of top 15 holdings out of 15
13.94%
DWAS
Total weight of top 15 holdings out of 15
18.84%
Top 15 holdings
Data as of August 31, 2026
SLYG
Corcept Therapeutics, Inc.
1.25%
Brinker International, Inc.
1.13%
ViaSat, Inc.
1.05%
Protagonist Therapeutics, Inc.
1.03%
Ryman Hospitality Properties, Inc.
1.00%
FormFactor, Inc.
0.90%
Alkermes Plc
0.90%
Etsy, Inc.
0.89%
Armstrong World Industries, Inc.
0.85%
Glaukos Corp.
0.84%
StoneX Group, Inc.
0.83%
TG Therapeutics, Inc.
0.82%
Federal Signal Corp.
0.82%
Zurn Elkay Water Solutions Corp.
0.82%
ESCO Technologies, Inc.
0.81%
DWAS
Erasca, Inc.
1.80%
Sezzle, Inc.
1.44%
Enova International, Inc.
1.40%
Climb Bio, Inc.
1.31%
Agilon Health, Inc.
1.30%
Bel Fuse, Inc.
1.28%
Tango Therapeutics, Inc.
1.22%
Acadian Asset Management, Inc.
1.20%
Oruka Therapeutics, Inc.
1.19%
AXT, Inc.
1.17%
Amneal Pharmaceuticals, Inc.
1.16%
Graham Corp.
1.12%
Frequency Electronics, Inc.
1.09%
Victory Capital Holdings, Inc.
1.09%
Aehr Test Systems
1.07%
Frequently asked questions about SLYG and DWAS
How have the SLYG and DWAS ETFs performed in 2026?
As of October 28, 2026, SLYG is up 16.87% year-to-date (YTD), while DWAS has returned 10.9%. That puts SLYG better performer ahead so far this year.
Which ETF is attracting more investor money: SLYG or DWAS?
Year-to-date, the SLYG ETF saw +$493M in flows, compared to -$407M for DWAS.
Which ETF is more volatile: SLYG or DWAS?
Over the past year, SLYG had a volatility of 16.85%, while DWAS experienced 25.63%.
Which ETF is bigger: SLYG or DWAS?
As of October 28, 2026, SLYG holds $4.69 B in assets under management (AUM), while DWAS manages $399.04 M.
What sectors do the SLYG and DWAS ETFs invest in?
SLYG leans toward sectors like Finance, Industrials and Healthcare. Meanwhile, DWAS focuses on Healthcare, Technology and Finance.
What are the top holdings of the SLYG ETF and DWAS ETF?
SLYG top holdings include Corcept Therapeutics, Inc., Brinker International, Inc. and ViaSat, Inc.. DWAS holds in its top three: Erasca, Inc., Sezzle, Inc. and Enova International, Inc..
Which ETF is more diversified: SLYG or DWAS?
SLYG holds 348 securities with 13.94% of its assets in the top 15. DWAS has 200 securities and a top 15 weight of 18.84%.
Advertisement
Advertisement
